TB PrEP - Integrating HIV prevention with TB household contact evaluation
Project Number1R01MH134685-01A1
Former Number1R01MH134685-01
Contact PI/Project LeaderROSS, JENNIFER M
Awardee OrganizationUNIVERSITY OF WASHINGTON
Description
Abstract Text
ABSTRACT
HIV and TB are leading and linked global epidemics. Household members of people with TB have an elevated
prevalence and incidence of both TB and HIV. HIV pre-exposure prophylaxis (PrEP) reduces HIV acquisition by
>90%, and both WHO and the Uganda Ministry of Health recommend PrEP as part of a comprehensive
prevention package for HIV-negative persons with substantial exposure to HIV. New implementation approaches
are needed to ensure that PrEP reaches all people who could benefit. A promising implementation approach to
increase PrEP access is through household-based TB contact investigation, which is a leading strategy to
decrease TB morbidity and mortality, particularly in high-incidence settings like Uganda. Care models that
integrate HIV testing in household TB contact investigation are being evaluated. However, PrEP has not been
integrated into TB household contact investigation in high-prevalence settings.
Recently, we found that couples identified in households affected by TB in Kampala, Uganda were twice
as likely to be serodifferent for HIV than couples in the general population (16% vs. 8%), suggesting that people
living in TB-affected households may benefit from PrEP. Multiple studies have shown that household-based
linkage to PrEP is feasible and effective in high HIV-burden settings, including among HIV serodifferent couples
and pregnant people. We therefore propose to adapt the proven intervention of PrEP to a new setting of
household TB contact investigation and evaluate its implementation, effectiveness, and costs using the RE-AIM
implementation framework, a widely used framework for evaluating how proven interventions perform in a new
delivery context. We hypothesize that integrating HIV prevention into household TB contact investigation will be
a feasible, acceptable, effective, and cost-effective strategy for expanding access to status-neutral HIV services,
including HIV self-testing and linkage to antiretroviral therapy and PrEP.
In Aim 1, we assess the implementation and effectiveness of home-based HIV self-testing and PrEP
initiation versus standard clinic referral for PrEP during household TB contact evaluation in Uganda. We use a
household-randomized trial design and test the hypothesis that home-based PrEP initiation will increase PrEP
uptake and retention compared to clinic referral. In Aim 2, we use qualitative methods to examine the processes
of implementing HIV self-testing and PrEP during household TB contact investigation. In Aim 3, we estimate the
cost-effectiveness of the strategy to integrate home-based HIV testing and PrEP with household TB contact
investigation to assess its sustainability. This work is impactful because understanding how to offer HIV self-
testing and PrEP in the setting of household TB contact investigation will facilitate increased use of PrEP, an
underutilized innovation for HIV prevention, by leveraging existing health programs.
Public Health Relevance Statement
NARRATIVE
HIV and tuberculosis (TB) are two infections that often occur among members of the same household and
cause a high number of deaths globally. This study tests an implementation strategy to include HIV testing and
medications to prevent HIV infection as part of public health outreach to household members of people with TB
in Uganda. We hypothesize that this approach could reduce HIV infections by leveraging existing TB public
health programs to also deliver medications to prevent HIV.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AIDS preventionAdolescentAdultAffectAfrica South of the SaharaBiological AssayCaringCause of DeathCessation of lifeClinicCommunitiesComplementCost Effectiveness AnalysisCounselingCouplesDataEffectivenessEligibility DeterminationEnrollmentEpidemicEvaluationExposure toFutureGeneral PopulationGuidelinesHIVHIV InfectionsHIV SeronegativityHIV/TBHealthHigh PrevalenceHomeHouseholdHuman immunodeficiency virus testIncidenceInfectionInterventionInterviewInvestigationLinkModelingMorbidity - disease rateMotionOutcomeParticipantPersonsPharmaceutical PreparationsPrevalencePreventionProcessProtocols documentationPublic HealthPulmonary TuberculosisQualitative MethodsRandomizedReach, Effectiveness, Adoption, Implementation, and MaintenanceRecommendationResearch PersonnelServicesTenofovirTestingTimeTuberculosisUgandaUrineWorkacceptability and feasibilityantiretroviral therapycare deliverycostcost effectivecost effectivenesscost estimateeconomic impactimplementation evaluationimplementation frameworkimplementation outcomesimplementation strategyimplementation trialinnovationintervention participantsmarginalized communitymathematical modelmembermicrocostingmortalitymultidisciplinaryoutreachperson centeredpre-exposure prophylaxispregnantpreventprimary outcomeprogramsrandomized trialscale upscreeningself testingstandard of caretrial designuptake
No Sub Projects information available for 1R01MH134685-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01MH134685-01A1
Patents
No Patents information available for 1R01MH134685-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01MH134685-01A1
Clinical Studies
No Clinical Studies information available for 1R01MH134685-01A1
News and More
Related News Releases
No news release information available for 1R01MH134685-01A1
History
No Historical information available for 1R01MH134685-01A1
Similar Projects
No Similar Projects information available for 1R01MH134685-01A1